News Daily News Donor Hearts Fare Better With Novel Method After Circulatory Death Michael O'Riordan May 01, 2025
News Daily News Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now Yael L. Maxwell April 25, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF Michael O'Riordan March 03, 2025
News Daily News Sotagliflozin Reduces Ischemic Risk in SCORED Analysis Yael L. Maxwell February 25, 2025
News Conference News THT 2025 Positive Results With Carillon Mitral Device Seen in Real-world Registries Todd Neale February 21, 2025
News Conference News THT 2025 Questioning the KCCQ: Experts Debate Its Validity as QoL Metric Todd Neale February 19, 2025
News Conference News THT 2025 HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt Todd Neale February 18, 2025
News Conference News THT 2025 Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity Todd Neale February 12, 2025
News Daily News Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit Yael L. Maxwell February 12, 2025
Presentation THT 2025 Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial Presenter: Marat Fudim February 12, 2025
News Conference News THT 2025 Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT Todd Neale February 11, 2025
Presentation THT 2025 Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results Presenter: Javed Butler February 11, 2025
Presentation THT 2025 Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial Presenter: Sanjiv Shah February 11, 2025
News Daily News Surgeons Formalize Support for ESC’s Stance on CCS Revascularization Michael O'Riordan January 20, 2025
News Daily News Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3 Yael L. Maxwell January 15, 2025
News Daily News Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit Michael O'Riordan January 13, 2025